Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
about
The current status of treatment for colorectal cancer in China: A systematic review.Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial.A phase I study to investigate the metabolism, excretion, and pharmacokinetics of [14C]fruquintinib, a novel oral selective VEGFR inhibitor, in healthy Chinese male volunteers."Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer.
P2860
Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and efficacy of fruquin ...... ed double-blind phase II study
@en
Safety and efficacy of fruquin ...... d double-blind phase II study.
@nl
type
label
Safety and efficacy of fruquin ...... ed double-blind phase II study
@en
Safety and efficacy of fruquin ...... d double-blind phase II study.
@nl
prefLabel
Safety and efficacy of fruquin ...... ed double-blind phase II study
@en
Safety and efficacy of fruquin ...... d double-blind phase II study.
@nl
P2093
P2860
P1476
Safety and efficacy of fruquin ...... ed double-blind phase II study
@en
P2093
Dongsheng Zhang
Hongming Pan
Jianming Xu
Junning Cao
Liwei Wang
Rui-Hua Xu
Songhua Fan
Tianshu Liu
P2860
P2888
P356
10.1186/S13045-016-0384-9
P577
2017-01-19T00:00:00Z
P6179
1003872654